Publications by authors named "J Kassa"

The current pharmacological pretreatment and medical treatment of nerve agent poisoning is an insufficiently addressed medical task. The prophylactic efficacy of a novel compound acting dually as an acetylcholinesterase inhibitor and NMDA receptor antagonist (K1959) and the therapeutic efficacy of a novel NMDA receptor antagonist (K2060) were evaluated in the NMRI mice model of nerve agent poisoning by tabun, soman and sarin. Their added value to the standard antidotal treatment (a combination of oxime reactivator and atropine) was also analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • N-methyl-D-aspartate receptors (NMDARs) are crucial in various CNS disorders, with current treatments like memantine and ketamine having limitations and side effects.
  • Researchers aimed to create a new NMDAR open-channel blocker, K2060, which displays unique inhibitory properties and stronger effectiveness than existing drugs at inhibiting specific NMDAR subtypes.
  • K2060 showed promising results in a mouse model, reducing excitatory postsynaptic currents significantly and exhibiting a good safety profile, suggesting its potential as a treatment for NMDAR-related CNS disorders.
View Article and Find Full Text PDF

Organophosphorus nerve agents pose a global threat to both military personnel and civilian population, because of their high acute toxicity and insufficient medical countermeasures. Commonly used drugs could ameliorate the intoxication and overall medical outcomes. In this study, we tested the drugs able to alleviate the symptoms of Alzheimer's disease (donepezil, huperzine A, memantine) or Parkinson's disease (procyclidine).

View Article and Find Full Text PDF

Oxime reactivators are causal antidotes for organophosphate intoxication. Herein, the toxicity, pharmacokinetics, and reactivation effectiveness of o-chlorinated bispyridinium oxime K870 are reported. Oxime K870 was found to have a safe profile at a dose of 30 mg/kg in rats.

View Article and Find Full Text PDF

The therapeutic efficacy of treatments for acute intoxication with highly toxic organophosphorus compounds, called nerve agents, usually involves determination of LD values 24 h after nerve agent challenge without and with a single administration of the treatment. Herein, the LD values of four nerve agents (sarin, soman, tabun and cyclosarin) for non-treated and treated intoxication were investigated in mice for experimental end points of 6 and 24 h. The LD values of the nerve agents were evaluated by probit-logarithmical analysis of deaths within 6 and 24 h of i.

View Article and Find Full Text PDF